QA: Merus N.V. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651311_2022_Merus_N_V.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 49107000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001651311, Merus N.V.

  xvar xval
0 AssetsCurrent 424,179,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,549,000
3 remainder_Assets 28,872,000
4 LiabilitiesCurrent 71,898,000
5 LiabilitiesNoncurrent 2,257,000
6 remainder_Liabilities 66,244,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 40,896,000
9 ResearchAndDevelopmentExpense 98,187,000
10 remainder_Expenses 239,000
11 remainder_Revenues 49,107,000
12 remainder_NetIncome 23,399,000
13 remainder_ComprehensiveNetIncome -18,292,000
  yvar yval
0 Assets 456,600,000
1 Liabilities 140,399,000
2 Expenses 139,322,000
3 Revenues 49,107,000
4 StockholdersEquity 316,201,000
5 NetIncome -66,816,000
6 ComprehensiveNetIncome -75,962,000
7 BaseVar 413,559,500
8 EconomicCapitalRatio 1.57

Edgar->Model Mapping

Feature Distribution

Change over Time